Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia

Circulation

Volumn 112, Issue 9 SUPPL., 2005, Pages

  Feng, Jun ^a   Bianchi, Cesario ^a   Sandmeyer, Jennifer L ^a   Li, Jianyi ^a   Sellke, Frank W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cardioplegia; Microcirculation; Reperfusion; Transplantation

Indexed keywords

BUFFER; CASPASE 3; GENE PRODUCT; KREBS HENSELEIT BUFFER; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CARDIOPLEGIA; COLD BLOOD CARDIOPLEGIA; COLD CRYSTALLOID CARDIOPLEGIA; CONTROLLED STUDY; CRYSTALLOID; ENDOTHELIUM DEPENDENT RELAXATION; ENZYME ACTIVATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; INTERMITTENT BLOOD CARDIOPLEGIA; INTERMITTENT CRYSTALLOID CARDIOPLEGIA; ISOLATED HEART; MICROCIRCULATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; RABBIT; VASODILATATION; WARM BLOOD CARDIOPLEGIA; WARM CRYSTALLOID CARDIOPLEGIA;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BIOLOGICAL MARKERS; BLOOD; CARDIOPLEGIC SOLUTIONS; CASPASE 3; CASPASES; COLD; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEART; HEART ARREST, INDUCED; IN SITU NICK-END LABELING; MICROCIRCULATION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHORYLATION; POTASSIUM COMPOUNDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; RANDOM ALLOCATION; TEMPERATURE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 24644444754     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.526160     Document Type: Article

References (19)

1. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
2. Saraste A, Pulkki, K, Kallajoki, M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human myocardial infarction. Circulation. 1997;95:320-323.
3. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor apaf apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 1996;94:1506-1512.
4. Tanaka M, Nakae S, Terry RD, Mokhtari GK, Gunawan F, Balsam LB, Kaneda H, Kofidis T, Tsao PS, Robbins RC. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood. 2004;104:3789-3796.
5. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-X(L). Cell. 1996;87:619-628.
6. Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Nakao K. Cardiotrophin-1 phosphorylates Akt and Bad, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol. 2000;32:1385-1394.
7. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-1198.
8. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart. Circ Res. 2002;90:390-397.
9. Uchiyama T, Engelman RM, Maulik N, Das DK. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation. 2004 22;109:3042-3049.
10. Cooper WA, Duarte IG, Thourani VH, Nakamura M, Wang NP, Brown WM 3rd, Gott JP, Vinten-Johansen J, Guyton RA. Hypothemic circulatory arrest causes multisystem vascular endothelial dysfunction and apoptosis. Ann Thorac Surg. 2000;69:696-703.
11. Schmitt JP, Schrader J, Schunkert H, Birnbaum DE, Aebert H. Role of apoptosis in myocardial stunning after open-heart surgery. Ann Thorac Surg. 2002;73:1229-1235.
12. Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest. 2003;123:1647-1654.
13. Fischer UM, Klass O, Stock U, Easo J, Geissler HJ, Fischer JH, Bloch W, Mehlhorn U. Cardioplegia arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes. Eur J Cardio Thorac Surg. 2003;23:984-990.
14. Barner HB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg. 1991;52:1354-1367.
15. Sellke FW, Shafique T, Johnson RG, Dai HB, Banitt PF, Scboen FJ, Weintraub RM. Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg. 1993;55:977-985.
16. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481-490.
17. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 2003;75:S656-S60.
18. Steenbergen C, Afsharl CA, Petranka JG, Collins J, Martin K, Bennett L, Haugen A, Bushel P, Murphy E. Alterations in apoptosis signaling in human idiopathic cardiomyopathic hearts in failure. AM J Physiol. 2003;284:H268-H276.
19. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 2000;45:6651-6660.